EMA issues first paediatric use positive opinion
This article was originally published in SRA
Executive Summary
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued its first ever positive opinion for paediatric use marketing authorisation (PUMA) under the new Paediatric Regulation that came into force in 20071.